Showing results (1-10 of 248) with videos related to
Sort By:
Pageof 25
F1000Research|August 9, 2016
Recent advances in phototherapy for psoriasisMio Nakamura, Benjamin Farahnik, Tina BhutaniCutis|March 13, 2018
Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapiesMio Nakamura, Michael Abrouk, Benjamin Farahnik, et al.Journal of Drugs in Dermatology : JDD|July 12, 2017
Update on the Systemic Risks of Superpotent Topical SteroidsMio Nakamura, Michael Abrouk, Henry Zhu, et al.The Journal of Dermatological Treatment|February 4, 2016
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A reviewTian Hao Zhu, Mio Nakamura, Michael Abrouk, et al.The Journal of Dermatological Treatment|September 24, 2016
Obsessive-compulsive skin disorders: a novel classification based on degree of insightTian Hao Zhu, Mio Nakamura, Benjamin Farahnik, et al.The Journal of Dermatological Treatment|August 30, 2016
Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a reviewMio Nakamura, Kristina Lee, Rasnik Singh, et al.American Journal of Clinical Dermatology|March 4, 2016
The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation InjuryTian Hao Zhu, Mio Nakamura, Benjamin Farahnik, et al.Dermatology and Therapy|May 26, 2016
Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Michael Abrouk, et al.Dermatology and Therapy|February 25, 2016
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Tian Hao Zhu, et al.Journal of Drugs in Dermatology : JDD|March 9, 2016
Anti-IL-17 Agents for Psoriasis: A Review of Phase III DataBenjamin Farahnik, Kourosh Beroukhim, Mio Nakamura, et al.Pageof 25